Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Actually saw it closed over .20, and unfortunately this is Post Reverse Split and Post Jim Katzaroff era.
I would hate for GSTC to take the same route but with a Penny CEO at the helm its hard not to think it won’t.
Even if he does, we will drift to a level where there will be no more room for lenders to convert. We will go from 50 - 80 million share conversions to 120 mil - 180 mil conversions in the next quarter.
We will be nearly a 2 Bil o/s by Q3
This week might put the nail in the coffin
RDGL part 2. Reverse Split imminent
I’m saying that is probably the only way forward from here. No firm will touch this with a 10 foot pole at the first glance of financials. Any firm will ask for a R/S before even thinking about giving him money.
I would like to believe so, but there is just not much room for movement at this level. A bio company needs money, they do not have a product to sell at the moment. We will be a $0 revenue company for years to come and share price will be based on forward potential earnings.
There will be more shares converted in May and you better believe more notes were taken out in Q1 and most likely this Quarter as well so there will be more dilution in the summer months and then into the fall.
A CRO will not take this on without cash up front and the last filing shows about $0 in the bank.
There is no more room for toxic lenders at this level, so the only logical reasoning would be a reverse split (lets say a 1:25 or even a 1:50) would get the PPS in the low pennies and then start the funding routine all over again.
I hope I am wrong, but logic points to that direction unless management hires a magician and pulls a rabbit out of a hat.
This won’t go anywhere without a split
1:25 coming before summer. It’s sad this is the road this ticker went down.
He’s playing this as any other small cap bio that is preclinical. They dilute to oblivion and make sure the lenders make out okay while retail gets screwed. Then eventually R/S and repeat. The problem with this one is we are well below sub penny and there is no more room for lenders to play with. So an R/S would have to be imminent.
It is already being watched
It will come between 10am and 11am est. just like every other PR during dumping.
Oh trust me, he will get in trouble. Trades will be subpoenaed along with the timing of PR’s. And there is a lot of other evidence.
I don’t think anyone in their right mind would give him cash at this level. No room for conversion/make money. Retail will end up getting the shaft by hook or crook as we like to say here in the midwest.
We need a pharma CEO
All you have to do is look who is in and at what price. Then you can see what’s coming.
Flip .0005 - .0007 will be the new game until next note is due
Management had to get Valerian out on last run up to .0025 when their 33 mil became unrestricted so they can be protected. Old school OTC shenanigans. Valerian in at .00075 and Powerup will convert .000427 so management had to help Valerian get out somehow. New floor will be .0005. Notice the PR put out on the heavy day of dumping. We won’t be leaving .000’s for a long time.
Anyone can read then next move if you know where to look.
As it stands now, we’re looking at a 1,236,691,000 float for beginning of May.
The fact of the matter is this is and will remain in the gutter until management decides to stop using toxic lenders and substantial news released. None of that “beginning engagement” or “having talks with….” bullcrap.
Lol not gonna lie, this one is actually funny.
It’s been the same pattern quarter after quarter. Toxic lenders have full control here.
Heavy push down about to commence. Follow the money.
Next PR will most likely be between May 1st - May 6th. Will be hard to crack .001 here with the downward pressure that is being put on to this ticker.
Toxic lender wants .0005, they will ultimately get 105 million shares at .000305 upon conversion. Good luck finding someone to chew through a 100 million even at this level
Scary when there is no floor
We’ll be .0005 quicker than i thought
The next PR will be 1st week of may when note converts
GSTC RIP 01/01/2020 - 04/03/2024
.0005 by April 10th
Until the shenanigans stop, I would say you are correct. If it continues, it will ultimately lead to an R/S
.0004/.0005 incoming. This has become too predictable every time a note is about to be converted. A pattern has been created and it cannot be refuted. Something has to be done.
If I had to guess, most likely because management knew the dump was coming and they had to do something to absorb it and create liquidity. Funny how we only get a PR or update when liquidity is needed for dumping of shares.
If more notes were taken out with toxic lenders in Q1 2024 (we’ll know in the next Q by may 15th), I think we see an R/S before June.
We will be .0004/.0005 after April 10th. Trade with the lenders, only way to make cash
Anyone wanna guess the new O/S once it updates?
Taking bets.
I’ll go with 1,210,000,000
If he would just turn off the faucet, we could probably get above .01 with the right news.
When the $31,500 converts early may, we’ll balloon to approximately 1,240,000,000 O/S
If there is no stable source of funding other than toxic lenders from that point, it will be the nail in the coffin and a R/S will probably happen sometime in the near future.
Management has done one hell of a job here i’ll tell you that.
There’s literally no way to make any money here. The only money that can be made is the small flips on conversion pumps. No one will fund a “biotech” sitting with a .0009 share price in a 5% interest rate economy. The only funding would have to come with a conditional R/S and will screw everyone. Sad what this has come to.